Device Trial Radar · NCT06166901
Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)
Last checked: Nov 20, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
211
Actual
Start
Apr 27, 2024
Primary completion
Feb 5, 2025
Study completion Feb 5, 2025
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 12, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Post-Market Clinical Follow-up (PMCF) study is to describe the long-term safety and performance of the AcrySof IQ PanOptix IOL toric and non-toric models in subjects bilaterally implanted with these IOLs for 3 to 5 years. This study will be conducted in Spain.
Conditions
- Aphakia
- Astigmatism
- Presbyopia
Interventions
AcrySof IQ PanOptix IOL ToricDevice
Trifocal toric IOL implanted in the capsular bag in the eye for the visual correction of aphakia and pre-existing corneal astigmatism in adult patients with and without presbyopia who desire near, intermediate and distance vision with increased spectacle independence.
AcrySof IQ PanOptix IOL Non-ToricDevice
Trifocal IOL implanted in the capsular bag in the eye for the visual correction of aphakia in adult patients with less than 1.00 diopter of preoperative corneal astigmatism with and without presbyopia who desire near, intermediate and distance vision with increased spectacle independence.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Binocular Best Corrected Distance Visual Acuity (BCDVA)Time frame: Year 3-5 postoperative (Visit 1, Day 1)
- Number of Eyes Experiencing an Ocular Adverse Event by ToricityTime frame: Retrospective data from preoperative visit to Year 3-5 postoperative (Visit 1, Day 1)
- Number of Subjects Experiencing a Non-Ocular Adverse EventTime frame: Retrospective data from preoperative visit to Year 3-5 postoperative (Visit 1, Day 1)
1 more outcomes with a free account
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Barraquer Ophthalmology Center
Barcelona, Spain
Institut Catala de la Retina - Sarria
Barcelona, Spain
Hospital Arruzafa
Córdoba, Spain
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.